Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Abstract

The complete EBV seropositivity in this large cohort of patients with early MS strengthens the evidence for a role of EBV in MS. It also suggests that a negative EBV serology in patients with suspected inflammatory central nervous system disease should alert clinicians to consider diagnoses other than MS.